FDG PET/CT Utility in Gynecologic Malignancies: A comprehensive review of anatomy, pathways of metastatic spread and scan findings
Poster Nov 02, 2012
Nicholas Plaxton, MD, Aruna Polsani, MD, Raghuveer Halkar, MD, Karen Godette, MD, Barron, Bruce, MD
Our objective was to review the five major gynaecologic cancers (cervical, ovarian, uterine, vaginal, and vulvar) and demonstrate the role of FDG PET/CT in diagnosis, surveillance, FIGO staging and treatment strategy.
The Impact of MRI on Genitourinary and Gastrointestinal Toxicity after Radiation TherapyPoster
MRI has several advantages relative to other imaging modalities in evaluating, diagnosing, and planning treatment for prostate cancer. However, it is rarely ordered for localized disease. While the diagnostic abilities have been studied, little has been done to associate clinical outcomes with prostate cancer patients who received MRI.READ MORE
Change in pattern of secondary malignancies following Kaposi's sarcoma in the era of anti-retroviral therapyPoster
This study hypothesis is that the secondary cancers that develop in patients with KS have changed.READ MORE